Total Holdings
33
Portfolio diversification across 33 positions
FBT
(NYSEARCA)First Trust NYSE Arca Biotechnology Index Fund
$202.00-- (--)
Loading... - Market loading
FBT ETF Holdings: First Trust NYSE Arca Biotechnology Index Fund
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$2.28B
Total fund assets
Expense Ratio
0.54%
Annual management fee
Fund Issuer
First Trust
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 32 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Moderna, Inc. | Stock | 5.14% |
| 2 |  | Alkermes plc | Stock | 4.16% |
| 3 |  | United Therapeutics Corporation | Stock | 4.15% |
| 4 |  | Gilead Sciences, Inc. | Stock | 4.08% |
| 5 |  | Corcept Therapeutics Incorporated | Stock | 3.94% |
| 6 |  | Axsome Therapeutics, Inc. | Stock | 3.91% |
| 7 |  | Amgen Inc. | Stock | 3.81% |
| 8 |  | BioNTech SE | Stock | 3.63% |
| 9 |  | Krystal Biotech, Inc | Stock | 3.59% |
| 10 |  | argenx NV ADR | Stock | 3.53% |
| 11 |  | Exelixis, Inc. | Stock | 3.52% |
| 12 |  | Biogen Inc. | Stock | 3.45% |
| 13 |  | Neurocrine Biosciences, Inc. | Stock | 3.44% |
| 14 |  | Regeneron Pharmaceuticals, Inc. | Stock | 3.44% |
| 15 |  | BioMarin Pharmaceutical Inc. | Stock | 3.42% |
| 16 |  | Halozyme Therapeutics, Inc | Stock | 3.42% |
| 17 |  | Vertex Pharmaceuticals Incorporated | Stock | 3.40% |
| 18 | B BGNE | BeiGene, Ltd | Stock | 3.40% |
| 19 |  | Exact Sciences Corporation | Stock | 3.34% |
| 20 |  | Illumina, Inc | Stock | 3.33% |
| 21 |  | Bio-Techne Corporation | Stock | 3.30% |
| 22 |  | Natera, Inc | Stock | 3.28% |
| 23 |  | Sarepta Therapeutics, Inc. | Stock | 3.27% |
| 24 |  | ACADIA Pharmaceuticals Inc | Stock | 3.24% |
| 25 |  | Genmab A/S | Stock | 3.23% |
| 26 |  | BeOne Medicines AG | Stock | 3.21% |
| 27 |  | Incyte Corporation | Stock | 3.19% |
| 28 |  | NeoGenomics, Inc | Stock | 3.11% |
| 29 |  | Veracyte, Inc | Stock | 3.02% |
| 30 |  | Repligen Corporation | Stock | 3.01% |
| 31 |  | Alnylam Pharmaceuticals, Inc. | Stock | 2.91% |
| 32 |  | Bruker Corporation | Stock | 2.67% |
Frequently Asked Questions About First Trust NYSE Arca Biotechnology Index Fund Holdings
What are the top holdings in FBT?
First Trust NYSE Arca Biotechnology Index Fund (FBT) holds 33 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is FBT's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review FBT's holdings table to analyze concentration risk.
What is FBT's sector allocation?
The Sector Allocation chart shows how FBT distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does FBT invest in?
FBT's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is FBT ETF?
FBT's diversification can be assessed by reviewing its 33 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.